What is LOPJLB’s current signal on ATNM?

LOPJLB’s latest quantitative signal on Actinium Pharmaceuticals, Inc. (ATNM) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is ATNM in?

Actinium Pharmaceuticals, Inc. (ATNM) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does Actinium Pharmaceuticals, Inc. (ATNM) do?

Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing and commercializing treatments, primarily focusing on those for bone marrow transplant (BMT) or other cellular and adoptive cell therapies. Its leading drug candidate, I-131 apamistamab (known as Iomab-B), is currently in a crucial Phase III clinical trial for its role in conditioning elderly patie…

Where is Actinium Pharmaceuticals, Inc. based / listed?

Actinium Pharmaceuticals, Inc. is based in US, listed on AMEX.

Actinium Pharmaceuticals, Inc. (ATNM)

COMPARE

Healthcare · Biotechnology · AMEX · US

$1.08+0.93%Close

SELLCRISIS · day 3

[SCORES & PROFILE]

FUND: 27
VALUE: 35
GROWTH: 77
GARP: 14
TYPE: Value / Recovery (blended)

Composite of Value · Growth · GARP

ROIC50.1%

REV YoY-

ROE83.4%

EPS YoY-

ROA28.2%

GROSS

101

NET

[VALUATION]

P/E TTM3.08

P/E FWD-

SECTOR PE20.12

INDUSTRY PE13.79

P/B1.15

P/FCF-

EV/EBITDA-0.03

EV/EBIT-

PEG-

FCF YIELD-

RISK

INT COV-

D/E4.43

ALTMAN Z-

CURR RATIO4.08

ND/EBITDA-

BETA0.02

Actinium Pharmaceuticals, Inc. (ATNM)

Key stats

Prediction markets

FUNDAMENTALS

Company news